Skip to main content
. 2018 Oct 19;13(10):e0206067. doi: 10.1371/journal.pone.0206067

Table 1. Baseline characteristics.

Cycle 1 (n = 188) Cycle ≥ 2 (n = 286) p-value
Age (y.o.) 33.74 ± 4.39 33.94 ± 4.39 0.629 t
Age > 35 y.o. at retrieval 65 (34.57) 103 (36.01) 0.752 k
Smoker 17 (9.04) 29 (10.14) 0.689 k
BMI 23.65 ± 4.35 23.15 ± 4.00 0.237 t
BMI > 30 20 (10.64) 20 (6.99) 0.163 k
Type of infertility 0.920 k
    Primary 131 (68.68) 198 (69.23)
    Secondary 57 (30.32) 88 (30.77)
Length of the infertility (y.o.) 4.32 ± 2.46 4.54 ± 2.27 0.366 t
Cause of the infertility 0.461 k
    Ovulation disorder 17 (9.04) 30 (10.49)
    Male factor 50 (26.60) 76 (26.57)
    Tubal factor 30 (15.96) 27 (9.44)
    Endometriosis 33 (17.55) 47 (16.44)
    Idiopathic 27 (14.36) 48 (16.78)
    Diminished ovarian reserve 2 (1.06) 5 (1.75)
    More than one cause 29 (15.43) 53 (18.53)
Numbers of previous IVF/ICSI attempts 0.131 k
    1 106 (56.38) 171 (59.79)
    2 29 (15.43) 56 (19.58)
    > 3 53 (28.19) 59 (20.63)
Ovarian reserve
    FSH (U/L) 6.29 ± 1.86 6.34 ± 1.68 0.747 t
    FSH > 8 22 (11.70) 36 (12.59) 0.777 k
    AMH (ng/mL) 5.80 ± 4.19 5.58 ± 4.06 0.576 t
    AMH < 2 25 (13.30) 37 (12.94) 0.920 k
    AFC 20.56 ± 10.65 21.20 ± 11.69 0.547 t
    AFC < 10 23 (12.23) 35 (12.24) 0.999 k
Indications for FBT 0.154 k
    Risk of OHSS 81 (43.09) 128 (44.76)
    Elevated progesterone or inadequate endometrium 11 (5.85) 30 (10.49)
    Endometriosis 36 (19.15) 55 (19.23)
    Two or more ART failures 47 (25.00) 49 (17.13)
    Autoimmune disease and/or a high risk of thromboembolic disease 13 (6.91) 24 (8.39)

y.o., years old; BMI, body mass index; IVF/ICSI, in vitro fertilization/ intra-cytoplasmic sperm injection; AFC, antral follicle count; AMH, anti-Müllerian hormone; FSH, follicle stimulating hormone; FBT, frozen blastocyst transfer; OHSS, ovarian hyperstimulation syndrome; ART, assisted reproductive technologies. Data are the mean ± standard error or n (%), unless specified otherwise.

t Student’s t-test

k Pearson’s chi-square test